Ranbaxy Granted 60 Days To Produce Audit Documents in DOJ Investigation
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Maryland District Court Judge Peter Messitte has granted a sixty day "abeyance" from a motion filed by the U.S. Department of Justice against Ranbaxy on charges of concealing information regarding one of its manufacturing plants in India